InsiderTrades.com logo

TVGN Insider Trading

Insider Ownership Percentage: 73.24%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,215,755.88

Tevogen Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Tevogen Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tevogen Bio Share Price & Price History

Current Price: $0.42
Price Change: ▼ Price Decrease of -0.0059 (-1.38%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for TVGN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Tevogen Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2025Ryan H SaadiCEOSell1,438,206$1.23$1,768,993.38116,814,453View SEC Filing Icon  
3/12/2025Neal FlomenbergInsiderSell232,968$1.09$253,935.123,595,608View SEC Filing Icon  
3/10/2025Neal FlomenbergInsiderSell70,384$1.09$76,718.563,898,828View SEC Filing Icon  
3/6/2025Neal FlomenbergInsiderSell88,519$1.10$97,370.904,040,485View SEC Filing Icon  
3/4/2025Neal FlomenbergInsiderSell14,639$1.28$18,737.924,239,663View SEC Filing Icon  
10/17/2024Neal FlomenbergInsiderSell1,078,600$1.62$1,747,332.004,254,302View SEC Filing Icon  
6/12/2024Kirti DesaiCFOBuy3,000$0.82$2,460.009,699,186View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Tevogen Bio (NASDAQ:TVGN)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TVGN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tevogen Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2025Bridgeway Capital Management LLC82,500$65K0.0%+66.7%0.042%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.54,761$59K0.0%-29.9%0.030%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC90,253$97K0.0%N/A0.049%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp118,415$0.12M0.0%+13.0%0.068%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd53,858$55K0.0%N/A0.031%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC45,600$48K0.0%+39.2%0.026%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC451,851$0.47M0.0%+31.2%0.258%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.39,207$40K0.0%+74.2%0.022%Search for SEC Filing on Google Icon
1/24/2025China Universal Asset Management Co. Ltd.37,117$38K0.0%N/A0.021%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.1,577,387$0.58M0.0%-20.6%0.924%Search for SEC Filing on Google Icon
11/15/2024HGC Investment Management Inc.223,077$82K0.0%N/A0.131%Search for SEC Filing on Google Icon
5/9/2024Portland Global Advisors LLC5,782,209$21.68M3.0%N/A36.550%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tevogen Bio logo
Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Read More on Tevogen Bio

Today's Range

Now: $0.42
Low: $0.41
High: $0.43

50 Day Range

MA: $0.58
Low: $0.39
High: $0.80

52 Week Range

Now: $0.42
Low: $0.38
High: $1.92

Volume

239,853 shs

Average Volume

457,631 shs

Market Capitalization

$83.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Tevogen Bio?

Tevogen Bio's top insider investors include:
  1. Ryan H Saadi (CEO)
  2. Kirti Desai (CFO)
  3. Neal Flomenberg (Insider)
Learn More about top insider investors at Tevogen Bio.

Who are the major institutional investors of Tevogen Bio?

Tevogen Bio's top institutional investors include:
  1. Bridgeway Capital Management LLC — 0.04%
Learn More about top institutional investors of Tevogen Bio stock.

Which institutional investors are buying Tevogen Bio stock?

During the previous quarter, TVGN stock was acquired by institutional investors including:
  1. Bridgeway Capital Management LLC